{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Vancouver",
      "address_1": "14301 Se 1st St",
      "reason_for_recall": "Labeling:Label Mixup; carBAMazepine ER, Capsule, 200 mg may be potentially mislabeled as    ACAMPROSATE CALCIUM DR, Tablet, 333 mg, NDC 00456333001, Pedigree: AD46333_1, EXP: 5/15/2014.",
      "address_2": "",
      "product_quantity": "229 Capsules",
      "code_info": "carBAMazepine ER, Capsule, 200 mg has the following code    Pedigree: AD32764_14, EXP: 5/14/2014.",
      "center_classification_date": "20140116",
      "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.",
      "state": "WA",
      "product_description": "carBAMazepine ER, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 66993040832",
      "report_date": "20140122",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Aidapak Services, LLC",
      "recall_number": "D-719-2014",
      "initial_firm_notification": "Telephone",
      "product_type": "Drugs",
      "event_id": "65707",
      "termination_date": "20140207",
      "more_code_info": "",
      "recall_initiation_date": "20130702",
      "postal_code": "98684-3501",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}